EKF Diagnostics, a manufacturer of medical devices, has been awarded a contract to supply the State of New Mexico's Women, Infants, and Children (WIC) clinics with its point-of-care haemoglobin testing instrument.
The initial order is for 220 instruments which will be supplied to over 100 WIC clinics throughout the US State and will be used to carry out tests for anemia.
Anemia is one of the most common blood conditions in the US, affecting about 3.5m Americans.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
An initial indication from the New Mexico WIC clinics suggests that they expect to perform more than 160,000 tests per year using the HemoPoint H2 instrument.
Julian Baines, Chief Executive of EKF, said: "Following on from our recent trading update, which showed strong trading for 2011 ahead of expectations, the news of this contract win reinforces our belief that EKF will deliver continued organic growth in 2012, particularly as we ramp up sales of our HemoPoint H2 instruments in the key market of North America."
The share price rose 5% to 26.25p by 09:36.
NR
-
FTSE 100 hits record highs – why is it rising and will we see more gains?Advice UK equities have been described as unloved for a long time but as the FTSE 100 hits new highs, we explain if now is the time to buy British.
-
How to invest in copperIt may be time to invest in copper as the red metal appears poised for a big jump. Dominic Frisby looks at what should investors should buy
